Dr. Mustafa Abdulrahman Aljasser, B.Sc., MBA, is an innovative professional whose expertise spans the Pharmaceutical, Medical Devices, and Regulatory Sectors. He currently serves as Chief Business Officer at Sudair Pharmaceutical Company (SPC) and also acts as Chief Commercial Officer. Dr. Mustafa is deeply committed to advancing access to effective, safe, and high-quality medications for patients across the Kingdom and beyond, with a particular focus on Oncology and Advanced Therapeutics.

He has been consistently engaged in scientific conferences and symposia related to pharmaceutical quality, safety, oncology, and vaccination. He is a Board Member of the Saudi Pharmaceutical Society, Founder and Board Member of the Pharmaceutical Industry Association, and a Member of the National Committee for the Pharmaceutical Industry at the Federation of Saudi Chambers.

Dr. Mustafa Abdulrahman Aljasser holds a Bachelor of Science in Pharmacy from King Saud University and two Master’s degrees in distinct disciplines: a Master of Business Administration from Saudi Electronic University and a Master in Health Economics and Pharmacoeconomics from the Barcelona School of Management, UPF University. He previously served as Director of Regulatory Affairs and Government Relations at SPC and held a regulatory role at the Saudi Food & Drug Authority (SFDA) as Supervisor of Update and Renewal Registration.

Throughout his career, Dr. Mustafa has pursued continuous training across multiple domains, including leadership, quality management, crisis response, financing, security devices, medication safety, and regulatory affairs. His multidisciplinary background supports his ongoing contributions to the development and localization of Saudi Arabia’s pharmaceutical and healthcare sector.